Filing Details
- Accession Number:
- 0000899243-20-027231
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-05 16:05:33
- Reporting Period:
- 2020-10-02
- Accepted Time:
- 2020-10-05 16:05:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1736359 | M James Mock | 940 Winter Street Waltham MA 02451 | Please See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-10-02 | 1,100 | $123.69 | 31,741 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-10-02 | 4,423 | $124.58 | 27,318 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-10-02 | 100 | $125.08 | 27,218 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on September 2, 2020.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $122.95 to $123.93 The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $123.99 to $124.98. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.